🚨 BREAKING: Systemic Sclerosis (SSc) isn’t just about Raynaud’s! 🖐️💥 New data from US cohorts (GENISOS & CONQUER) reveals game-changing insights for early detection! 🩺🔍 Here’s why you NEED to know this:
1️⃣ Non-Raynaud’s Symptoms STEAL the Spotlight! 😱 Up to 44% of SSc patients don’t start with Raynaud’s—puffy fingers/hands are the REAL early warning! (40-53% of cases) 🤯
#MindBlown
2️⃣ Racial Disparities Uncovered 🌍 Black patients are ~50% more likely to show non-Raynaud’s symptoms first. Let’s talk
#HealthEquity! ✊
3️⃣ Severe Disease ALERT ⚠️ Non-Raynaud’s patients face higher rates of diffuse SSc, thicker skin, and joint issues (p<0.001). Time’s ticking! ⏰
4️⃣ Diagnostic Drama 🕵️♀️ RNA polymerase III antibodies (linked to severe SSc) are often MISSED in standard tests.
#FixTheGap
5️⃣ Race Against Fibrosis 🏃♂️ Non-Raynaud’s symptoms mean FASTER skin scarring—early diagnosis is EVERYTHING! 💉
6️⃣ Research Revolution 📊 Non-Raynaud’s patients MUST be included in studies to crack SSc’s code! 🔬
#ScienceForAll
💡 Don’t miss these CRITICAL clues for catching SSc early—especially for high-risk groups!
💙
#SystemicSclerosis #Rheumatology #EarlyDiagnosis #AutoimmuneAwareness #MedTwitter
🔗 DOI: 10.1002/art.42322